Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Malignant Solid Tumors × asciminib × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

P1b: Advanced Solid Tumors 1 Malignant Solid Tumors 1 Advanced Solid Tumors 1

Interventions

tislelizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 olaparib 1 asciminib 1 Topotecan 1 Sirolimus 1 SAR125844 1 Injections 1 Etoposide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06629584 2026-02-17

Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia

M.D. Anderson Cancer Center

Phase 2 Recruiting

Other solid neoplasm

Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡